The association of inflammatory cytokines such as IL-6 and cognitive impairment in both prostate cancer patients undergoing ADT and AD patients merits further scrutiny with a focus on both cognitive measures and physiological effects. The gene discussed is IL6; the disease is Familial prostate cancer.